Volume 86 Issue 37 | pp. 38-40
Issue Date: September 15, 2008

Rethinking Schizophrenia

Advances could spur treatments for more symptoms than current drugs address
Department: Science & Technology, ACS News
Selective Drug
Pfizer's drug candidate for schizophrenia (stick model) blocks a specific phosphodiesterase enzyme. Protein surfaces contacting the drug are shown in a space-filling format. Amino acids and a water molecule that make contact with the drug are shown in ball-and-stick form.
You Do Not Have Access to C&EN Protected Content.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society